Quasaredge Acquisition Corp current report, 21 April 2026

Business Context and Reporting Period

QuasarEdge Acquisition Corporation, a Cayman Islands exempted company and emerging growth company, filed this Form 8-K on April 21, 2026. The report details the consummation of its Initial Public Offering (IPO) and the subsequent full exercise of the underwriters' over-allotment option.

Key Financial Metrics

  • Initial IPO Proceeds: 10,000,000 Units sold at $10.00 per Unit, generating $100,000,000 in gross proceeds (closed April 16, 2026).
  • Over-Allotment Proceeds: 1,500,000 additional Units purchased by underwriters at $10.00 per Unit, generating an additional $15,000,000 in gross proceeds (closed April 21, 2026).
  • Total Gross Proceeds: $115,000,000 from the combined IPO and over-allotment.
  • Securities Issued: Units consisting of one ordinary share and one right (entitling the holder to 1/4 of one ordinary share).
  • Trading Symbols: QREDU (Units), QRED (Ordinary Shares), QREDR (Rights) on the New York Stock Exchange.
  • Other Metrics: The filing text does not provide specific values for net profit, operating cash flow, margins, or debt levels, as this is a current report focused on capital raising events rather than operational performance.

Material Changes

The primary material change is the increase in the Company's capitalization and cash assets following the full exercise of the over-allotment option on April 21, 2026. This event increased the total number of Units sold by 15% compared to the initial offering.

Guidance, Outlook, and Risks

The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard regulatory disclosures. The report notes that an unaudited pro forma balance sheet reflecting the over-allotment is filed as Exhibit 99.1. No unusual items or contingencies were disclosed in the text of this report.

Investor Verification Checklist

  • Verify the final pro forma balance sheet (Exhibit 99.1) to confirm the exact cash balance and trust account funding after the over-allotment.
  • Confirm the specific terms of the rights included in the Units and their conversion mechanics.
  • Review the underwriting agreement to understand any remaining obligations or fees associated with the over-allotment.
  • Check subsequent filings for the Company's target acquisition timeline and criteria, as this 8-K only covers the capital raise.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.